Solutions for Your Toughest Development Challenges.
Charles River transforms drug development with 75+ years of expertise across Discovery, Safety Assessment, and Toxicology, from Lead Optimization to GLP/Non-GLP studies (General, Immunology, Genetic, Ocular, Neuro, Developmental, Reproductive, and more). With 150+ sites in 21 countries, we drive innovation through integrated solutions and groundbreaking initiatives like Virtual Control Groups (VCGs), blending science with machine learning to deliver transformative alternatives. Apollo™, our industry-leading platform, provides real-time access to study data, enabling faster decisions, advanced visualization, and self-serve analytics. At Charles River, we deliver precision, efficiency, and confidence to accelerate life-saving therapies—because every moment matters for patients in need.